baber/WOPTO huggingface dataset:
Patent GB-1331265-A (GB)
Title: Electronic switching circuit arrangements
IPC: H04N9/27
Filed: 1971-07-30
Abstract: 1331265 Cathode-ray tube; circuits REDIFON Ltd 30 July 1971 [14 Aug 1970] 39373/70 Heading H4T The final anode voltage (EHT), for a colour display cathode-ray tube of the type in which the colour reproduced is determined by the energy of the beam, is switched between the (different) required levels by means including a transistor drive amplifier and an output stage including a thermionic valve operating as a cathode-follower. As shown in Figs. 1 and 2, the output at terminal 26 of the transistor drive amplifier 1 controls, via an intermediate valve 2, a cathode-follower stage 3 connected between the EHT supply line 4 and the zero voltage line 5 by means of a potentiometer from which via line 11 a feedback voltage is supplied to the inverting input terminal 22 of amplifier 1. The gain of the latter, which comprises a multi-stage operational amplifier formed as an integrated circuit (detailed in Fig. 3, not shown) is limited to 1000 times by resistors 20 and 70 and the EHT output at terminal 67 is determined by the level of the input at terminal 22. Thus to produce the EHT appropriate to production of the colours Orange (8À0 KV), Yellow (9À8 KV) or Green (12À5 KV) an "enable" voltage is supplied to input 17, 18 or 19 respectively which "turns-on" transistor 40, 45 or 50 to connect into the circuit the resistors pairs 41, 42; 46, 47 or 51, 52. The latter together with resistor 16 form potential dividers which cause the input level at terminal 22 to be progressively reduced so that the increasing level at the output 26 causes the anode of valve 2 and the grid of valve 3 to become more positive and thus produce the increasing levels of EHT at terminal 67. When no "enable" voltage is applied to terminals 17, 18 or 19 the increased input at terminal 22 (determined by resistor claims 13, 14 and 15) causes the output 26 to be reduced driving the anode of valve 2 negatively so that valve 3 is cut-off and diode 66 conducts to supply an EHT level at terminal 67 of 6 KV which is the required EHT for production of the colour Red. A focusing voltage appropriate to the various levels of EHT is derived at terminal 68.
Patent GB-1332341-A (GB)
IPC: E01C23/04
Filed: 1970-10-22
Abstract: 1332341 Road surfacing apparatus SYSTEM RESEARCH Inc 22 Oct 1970 50219/70 Heading E1G [Also in Division B2] Mobile apparatus for surfacing, e.g. a road, with a rubber/asphalt composition, with concrete, or with sand, e.g. includes a forward material locating section with a rear wall 11, and a single driven roller 2 behind and below the bottom of wall 11. The apparatus runs on rails 1 and may be motorised. The roller may be manufactured by turning, or from a sheet of e.g. copper, and may be oil- or air-heated. The roller is driven by means adjustable independently of the speed of the apparatus, e.g. it may be driven manually by crank 17, or by an electric motor, via chain 16. A lubricating roller 5, fed from container 7 and driven by roller 2 has a covering of, e.g. lambs hide and lubricates roller 2. A web of reinforcing material, e.g. glass fibres, can be pressed into the surfacing from a roll 3 via rollers 2 and 4. The roller 2 is mounted so as to be disengageable at one end to allow the apparatus to turn. A traffic line can be formed using central plates 25 extending forward from wall 11. (For Figures see next page)
Patent GB-1336278-A (GB)
Title: Construction of newel pillar staircases
IPC: E04F11/16
Filed: 1972-03-07
Abstract: 1336278 Spiral staircases O KOLB 7 March 1972 10454/72 Headings E1B and E1S A process for the construction of a newel piller staircase comprises erecting the staircase structure with empty tread frames 2 and then filling the frames with cast in situ concrete 9. In the embodiment shown the channel section side members 4 of the frames are continued as a loop which is adjusted as a continuous newel pillar 1 by bolts 5 through struts 6. When the final position of the treads has been determined they are welded to the pillar 1. Finally concrete is cast in the tread frames using temporary shuttering 7. In a second embodiment each tread frame has an annular ring at its inner end, and the rings interengage in spigot and socket fashion to form a newel pillar. The rings are welded together when the final position has been determined and then concrete is cast down the pillar to form a reinforcing column, the treads then being filled with concrete. Tread covers of rubber, carpet, linoleum or felt may be added. Services may be included in the newel pillar.
Patent GB-1345013-A (GB)
Title: Float-operated valves
IPC: F16K33/00
Filed: 1971-02-09
Abstract: 1345013 Valves G E EDGINTON 2 May 1972 [9 Feb 1971] 4222/71 Heading F2V An adjustable link for mounting a float on a lever arm of a float assembly comprises two parts one of which has male screw-thread means for attachment to the float and the other has female means for mounting on the end of the screw-threaded end of a lever arm, the parts being relatively adjustable to offset one of said parts relatively to the other in a direction transverse of the lever arm when mounted on the lever arm. In one embodiment (Fig. 1) the adjustment is effected by a threaded bolt 4 and lock nuts 6. In a second embodiment (Fig. 3) the link comprises a part 13 notched at 21 and slidable in a second part 14 provided with a flexible tongue 20 for engaging the notches. Both parts 13 and 14 are made of moulded plastics.
Patent GB-1351184-A (GB)
Title: Dibenzoxazepine and dibenzothiazepine derivatives
IPC: C07D267/18
Filed: 1971-04-19
Abstract: 1351184 Dibenzoxazepine and dibenzothiazepine derivatives E R SQUIBB & SONS Inc 19 April 1971 [24 Feb 1970] 35695/73 Divided out of 1351183 Heading C2C Novel compounds of Formula I (in which A is C 1-6  alkylene, each of X and X<SP>1</SP> is halogen or haloalkyl, Y is O or S and each of m and n is 0, 1 or 2) are prepared (a) by reacting a compound of Formula II with a compound of formula X<SP>11</SP>-A-CN (where X<SP>11</SP> is halogen), or (b) for compounds I in which A is -CH 2 CHRCN, where R is H or C 1-4  alkyl, by reacting a compound II with a compound of formula CH 2  : CRCN. 5,11 - Dihydro - 7 - trifluoromethyl - dibenz- [b,e][1,4] - oxazepine is prepared by cyclizing 2 - formylamino - 4 - trifluoromethylphenyl 2- bromobenzyl ether to give 5,11-dihydro-7-trifluoromethyl - dibenz[b,e][1,4]oxazepine - 5- carboxaldehyde and hydrolysing this to give the desired product. 3,7-Dichloro-5,11-dihydrodibenz[b,e][1,4]oxazepine, 2 - bromo - 3 - chloro- 5,11 - dihydrodibenz[b,e][1,4]oxazepine and 3 - chloro - 5,11 - dihydrodibenz[b,e][1,4]- oxazepine are similarly prepared via corresponding carboxaldehydes. 2 - Bromo - 4 - chlorobenzyl 4 - chloro - 2- formylaminophenyl ether is prepared from 2- bromo - 4 - chlorobenzyl bromide via 2- bromo - 4 - chlorobenzyl 4 - chloro - 2 - nitrophenyl ether and 2 - bromo - 4 - chlorobenzyl 4 - chloro- 2 - aminophenyl ether hydrochloride. 2,5- Dibromo - 4 - chlorobenzyl 2 - formylaminophenyl ether and 2 - bromo - 4 - chlorobenzyl 2- formylaminophenyl ether are similarly prepared via corresponding nitro and amine compounds. 2 - Formylamino - 4 - trifluoromethylphenyl 2- bromobenzyl ether is prepared by reacting 2- amino - 4 - trifluoromethylphenol with formic acid to form 2 - formylamino - 4 - trifluoromethylphenol and reacting this with o-bromobenzyl bromide. 2 - Bromo - 4 - chlorobenzyl bromide is prepared by reacting 2-bromo-4-chlorotoluene with bromine in the presence of UV irradiation. 2,5 - Dibromo - 4 - chlorobenzyl bromide is similarly prepared. 2 - Bromo - 4 - chlorotoluene and 2,5 - dibromo-4-chlorotoluene are prepared by reacting 4-chlorotoluene with bromine.
Patent GB-1353582-A (GB)
Title: Instruments for analysing substances by determining their radiation absorption characteristics
IPC: G01J3/42
Filed: 1970-02-03
Abstract: 1353582 Spectrometers SIR HOWARD GRUBB PARSONS & CO Ltd 19 April 1971 [3 Feb 1970] 5076/70 Heading G2J  An instrument for analyzing substances by determining their radiation absorption characteristics, has two sets of optical components, through which is passed radiation from a single source, the components in each set being distributed substantially in a respective plane, and paths for radiation associated with each set lying in a plane parallel to the plane of the components, at least one path in each set between components being angled to at least another path in the plane of the paths, the two planes of the paths intersecting in a line perpendicular to radiation paths in each set, and a beam-splitting device common to each set is situated on the line of intersection of the radiation planes. As shown, the components may be supported on two flat plate members A and B, lying at an angle to each other. A source of IR is mounted on A, and directed by mirrors 2 and 3 to beam-splitter 4, whence the two beams are directed by reflecting means 10 and 11 into paths perpendicular to the plane of the diagram. The beams pass slits, beam choppers, wavelength selection devices, e.g. a grating or prism in a Littrow mounting, or an interference filter, reflected back to 10 and 11, and the beams then passed via lens 8 and mirror 7 to sample all 5 and thence to a photo-electric detector.
Patent GB-1353748-A (GB)
Title: Composition for addition to a central heating system or other  closed circuit water system
IPC: C23F11/08
Filed: 1970-05-04
Abstract: 1353748 Corrosion inhibition P S MUETZEL 4 May 1971 [4 May 1970] 21363/70 Heading C7E A corrosion-inhibiting composition for addition to a central heating system or other closed water system comprises (a) a soluble source of tetraborate ions (b) a cuprosolvency inhibitor (c) a source of heptonate or boroheptonate ions and (d) a source of (i) molybdate ions and phosphate ions of Formula P n O 3n+1 <SP>n+2-</SP> where n is an integer or (ii) nitrite ions. The composition may further comprise (e) a source of silicate and/or metasilicate and/or water dispersable silicone (f) a biocide (g) Na hexametaphosphate (h) a sodium phosphate and (i) a water-soluble lubricant. It may be solid, e.g. a free-flowing powder, or an aqueous (e.g. 15-35 wt per cent) solution. Preferred sources of the above are: (a) (c) and (d) (ii) -the Na salts (where NO 2 - and tetraborate are present the ratio NO 2 -: tetraborate is 10:90 to 90:10), (b) mercaptobenzothiazole and/or benzotriazole (d) (i) a mixture of Na molybdate and (NaPO 3 ) n . Na 2 O wherein the ratio Mo:P is approx. 12:1 (f) - dichlorodihydroxydiphenylmethane or HCHO and (i) ethylene glycol, polyethylene glycol, or ethyl -, methyl-, or hydroxyethyl-cellulose; use of the composition in iron- or steel-based systems is referred to.
Patent IL-100881-A (IL)
Title: Prophylactic lubricating composition and devices and method for using same
IPC: A61K9/00
Filed: 1992-02-06
Abstract: A prophylactic lubricant composition for use during sexual relations, includes: a) lubricant effective to reduce friction, thereby reducing the rupture of blood vessels during sexual relations, b) an effective amount of spermicidal antiseptic active against HIV and other viruses, said antiseptic destroying the human immunodeficiency virus and other viruses, said antiseptic immobilizing the sperm and reacting with vaginal mucosa to form a barrier to the penetration of sperm cells into the uterus; and c) an effective amount of a fungicide to prevent the growth of fungi in the vagina which grow in the absence of natural bacterial flora destroyed by the antiseptic; said composition having no substantial detrimental effect.
Patent IL-101766-A (IL)
Title: Liquid crystalline light modulating device and material
IPC: C09K19/02
Filed: 1992-05-01
Abstract: A method of selectively adjusting the intensity of reflection to obtain stable grey scale reflectance of colored light from a light modulating chiral nematic liquid crystal material is disclosed. The method comprises subjecting the material to an electric field pulse of sufficient duration and voltage to cause a first proportion of the chiral nematic material to exhibit a first optical state and a second proportion of the chiral nematic material to exhibit a second optical state, whereby the material will continuously reflect a selected intensity between a maximum and minimum that is proportional to the amount of the material in the first optical state.
Patent IL-103992-A (IL)
Title: Antiviral cobalt containing imidazole compounds
IPC: C07D235/20
Filed: 1992-12-06
Abstract: Compounds having the formula    <IMAGE>  II  wherein each A may be the same or different and is an alkyl group, a phenyl group or a substituted derivative of a phenyl group; Y may be the same or different and is hydrogen, an unbranched alkyl group, a halide or a group having the structure   <IMAGE>    wherein R is hydrogen, an alkoxide group, an alkyl group, or OH; B may be the same or different and each is hydrogen or an alkyl group; Z- is a soluble, pharmaceutically acceptable negative ion, and X may be the same or different and is an axial ligand selected from the group consisting of moieties having the formula:    <IMAGE>  IIa  The compounds and compositions thereof exhibit antiviral activity.
Patent IL-107008-A (IL)
Title: Combined cooling and heating process and equipment for room air conditioning
IPC: F25B9/00
Filed: 1993-09-14
Abstract: The invention relates to a combined cooling and heating process for air-conditioning a compartment (8) and also to a device for carrying out the process, in particular for use in passenger train carriages. With this process and device, it is possible to either cool or heat a compartment (8). If the compartment (8) is no longer to be cooled but heated, according to the invention two valves (23, 24) are reversed, and the process air flows through the units required for cooling, heat exchanger (5) and regenerator (6), without heat exchange. The air heated by the compressor (2, 3) passes to the useful-heat exchanger (7) via a bypass pipe (31). The air cooled in the useful-heat exchanger (7) but still under pressure is conveyed via a further bypass pipe (22) to a turbine (4), where it is relieved of pressure and is released to the environment. The air of the compartment (8) to be heated is here sucked in by a pre-compressor. <IMAGE>
Patent IL-110088-A (IL)
Title: Composite web of mutually parallel fibers in a matrix and their preparation
IPC: B29C65/50
Filed: 1994-06-22
Abstract: PCT No. PCT/NL94/00123 Sec. 371 Date Apr. 3, 1996 Sec. 102(e) Date Apr. 3, 1996 PCT Filed May 31, 1994 PCT Pub. No. WO95/00318 PCT Pub. Date Jan. 5, 1995The invention relates to a composite web comprising one elongated flat composite layer of mutually parallel fibers in a matrix, in which the fibers run at an angle alpha (differing from 0 DEG ) relative to the lengthwise direction of the web, and which in the lengthwise direction is made up of joined-up and connected web parts. This composite web can be used for continuously producing multi-layer composites. The composite layer of the composite web has no areas with overlap or gaps when placed in a multi-layer composite. The invention also relates to a method for the production of this composite web and of multi-layer composites.
Patent IL-110958-A (IL)
Title: Method of introducing material into eggs during early embryonic development
IPC: A01K43/00
Filed: 1994-09-13
Abstract: A method of introducing a substance (14) into a bird egg through the shell thereof comprises the steps of applying a seal (10) to the exterior of the shell, inserting an injection device (11) through the seal (10) and into the egg, injecting the substance (14) through the injection device (11) and into the interior of the egg, and withdrawing the injection device (11) from the egg through the seal (10). The method is particularly preferred for injecting substances into the albumin during the first quarter of incubation through the bottom of the egg when the small end (8) of the egg is oriented downward to prevent the introduction of air bubbles through the opening formed in the shell by the injection device (11). <IMAGE>
Patent IL-111133-A (IL)
Title: Phenylethyl and phenylpropylamines and pharmaceutical compositions containing same
IPC: A61P25/20
Filed: 1994-10-03
Abstract: PCT No. PCT/SE94/00860 Sec. 371 Date Oct. 26, 1994 Sec. 102(e) Date Oct. 26, 1994 PCT Filed Sep. 16, 1994 PCT Pub. No. WO95/09835 PCT Pub. Date Apr. 13, 1995Compounds of the general formula   <IMAGE>   or pharmaceutically acceptable salts thereof, wherein Z is a saturated or unsaturated 3 to 6 carbon chain, m is 2 or 3, R1 is a hydrogen atom, or a straight or branched C1-4 alkyl group, R2, R3 and R13 are situated in the ortho, meta, or para position of the phenyl ring and are the same or different and selected from the following groups: H, OH, OR14, halogen, CO2R9, CN, CF3, NO2, NH2, COCH3,OSO2CF3,OSO2CH3,CONR10R11, OCOR12, wherein R9, R12 and R14 is a straight or branched C1-4 alkyl group, R10 and R11 are the same or different and represents hydrogen or a straight or branched C1-6 alkyl group, R is 1)   <IMAGE>    or   <IMAGE>   or   <IMAGE>   or   <IMAGE>   wherein the variables are defined in the specification,  processes for their preparation, pharmaceutical preparations containing them and the use of the compounds in the treatment psychiatric disorders.
Patent IL-116637-A (IL)
Title: System for energy management in a building
IPC: G08C19/00
Filed: 1996-01-01
Abstract: An energy management and building automation system including a local area network or home automation data bus such as the CEBus. Each load is connected to the bus via a control module which may contain a circuit breaker to disconnect the load from the mains upon command or upon occurrence of a power outage. Current monitoring control modules measure load current and power monitor modules monitor power consumed by selected loads, both modules transmitting bus messages indicating load status and status changes. A first microcomputer preferably is external to the customer premises, adjacent the electric utility power meter. A second microcomputer preferably is inside the customer premises. The two microcomputers communicate with each other and with the various modules via the network/data bus. The first microcomputer communicates with the utility company via any appropriate communications link. The second microcomputer serves, in part, as an input/output terminal for the system, allowing the customer to set parameters and query the system as to power usage, displaying reports requested by the customer and messages transmitted by the utility company and by either microcomputer. The first microcomputer acts as a master controller and/or network server, communicating with the world outside the premises, as a communications gateway between voice, video and data services, and being the primary data collector and operator of load control modules; the second microcomputer provides certain backup functions. The utility company can access selected utilization data and control at least some loads via messages to the first microcomputer.
Patent IL-124396-A (IL)
Title: Substituted 4-(1h-benzimidazol-2yl-amino) piperidines and pharmaceutical compositions comprising them
IPC: C07D405/14
Filed: 1996-11-07
Abstract: The present invention relates to novel substituted piperidine derivatives of formula (1), stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.
Patent IL-153592-A (IL)
Title: Pharmaceutical composition containing ketoconazole
IPC: A61P17/06
Filed: 2002-12-23
Abstract: A pharmaceutical composition suitable for topical application comprising ketoconazole in a solution which comprises: (i) 13 to 50 wt % water; (ii) 45 to 85 wt % of an alcohol having a boiling point of less than 100° C.; and (iii) 2 to 30 wt % of a non-volatile, water miscible, non-ionic surface active agent; the ketoconazole being present in an amount of 0.5 to 3 st % relative to components (i), (ii) and (iii).
Patent IL-154313-A (IL)
Title: Teatcup liner series
IPC: A01J5/04
Filed: 2003-02-06
Abstract: A teatcup liner series, having n liners L1 through Ln, has at least one selected parameter which varies liner to liner to provide selectable milking characteristics. The teatcup liner series is produced by a cost advantaged manufacturing method. <IMAGE>
Patent IL-158229-A (IL)
Title: Vial adapter having a needle-free valve for use with vial closures of different sizes
IPC: A61J3/00
Filed: 2003-02-07
Abstract: A vial adapter (21) for interconnecting with drug vial closures (73) of different diameters, each closure having a seal (77), said drug vials terminating in an outwardly extending flange, the vial adapter (21) comprising: 
an adapter housing (23) having a first end (25) comprising a slotted shroud (27) with an inner periphery and a circular array of claws (28) extending radially inward from the periphery, and a second end (35); the adapter housing having a thickness at the inner periphery; 
the first end (25) including a base, a central sharpened cannula (33) extending from the base to perforate a vial's rubber stopper and provide fluid communication between the vial and the first end, wherein said circular array of claws (28) are oriented radially inwardly towards said sharpened cannula;  
wherein the circular array of claws comprises: 
a first set of rigid claws (29) having a first length 
a second set of hinged claws (31), each of which has a second length that is longer than the first length of the first set of claws, each of the second set of claws adapted to deflect and plastically deform when the adapter is placed over a closure exceeding a selected first diameter, thereby permitting the second set of claws to accommodate the larger closure size; and 
a resealable needle-free valve located at the second end of the adapter housing that opens to permit fluid flow upon insertion of a blunt cannula and closes to prevent fluid flow upon removal of such blunt cannula.
Patent IL-160484-A (IL)
Title: Accommodating lens assembly
IPC: A61F2/16
Filed: 2004-02-19
Abstract: An intraocular lens assembly for implantation in the posterior chamber of an eye has anchor portions with teeth rigid enough to penetrate the scleral wall of an eye. A method for implanting the lens includes the steps of: introducing the first haptic portion with a first anchor portion that includes a plurality of teeth projecting therefrom, into the posterior chamber of the eye until said teeth are anchored in the scleral wall at a desired location; and moving a second haptic portion with a plurality of teeth projecting therefrom, until said teeth are anchored in the scleral wall on the opposite side of the lens from the first anchor portion.
Patent IL-179438-A (IL)
Title: Levodopa prodrugs and compositions and uses thereof
IPC: A61K31/277
Filed: 2006-11-21
Abstract: Prodrugs of levodopa, methods of making prodrugs of levodopa, methods of using prodrugs of levodopa, and compositions of prodrugs of levodopa are disclosed.
Patent IL-182735-A (IL)
Title: Inhibitors of c-fms kinase
IPC: A61K/
Filed: 2007-04-22
Abstract: The invention is directed to compounds of Formula I: wherein A, X, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, colon cancer, stomach cancer, hairy cell leukemia and non-small lung carcinoma; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including arthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.